NCT04506593

Brief Summary

Develop a registry (list of patients) with accurate clinical motility diagnosis. This registry will help the doctors to identify the patients with specific disease conditions. It will also help in promoting future research in gastroenterology motility disorders

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
6mo left

Started Nov 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Nov 2014Nov 2026

Study Start

First participant enrolled

November 1, 2014

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2016

Completed
4.1 years until next milestone

First Posted

Study publicly available on registry

August 10, 2020

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

August 15, 2024

Status Verified

August 1, 2024

Enrollment Period

12 years

First QC Date

July 16, 2016

Last Update Submit

August 14, 2024

Conditions

Keywords

Eosinophilic esophagitisChronic intestinal pseudo-obstructionSmall Bowel dysmotilitySIBOVomitingFunctional dyspepsiaFunctional bloatingGastroparesis

Outcome Measures

Primary Outcomes (1)

  • Identification of patients by accurate motility diagnosis

    Motility diagnosis will be made by physicians with specialized in GI Motility, based on consensus diagnostic criteria. The information gathered from the database will be used to help promote future clinical development and research in GI motility disorders.

    .through study completion, an average of 10 years

Secondary Outcomes (2)

  • Patient Reported Outcome (PRO) Measurements in Patients with Small Intestinal Bacterial Overgrowth (SIBO)

    through study completion, an average of 10 years

  • Patient Reported Outcome (PRO) Measurements in Patients with Gastroparesis

    through study completion, an average of 10 years

Interventions

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All Patients who presented to the GI outpatient clinics, in-patient consult service, and outpatient endoscopy centers within the Division of Gastroenterology and Hepatology

You may qualify if:

  • Patients who presented to the GI outpatient clinics, in-patient consult service, and outpatient endoscopy centers within the Division of Gastroenterology and Hepatology
  • Carries a diagnosis of GI motility disorder based on the diagnostic criteria listed in table

You may not qualify if:

  • \. Coexisting medical conditions that may limiting participation in clinical research trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University Health University Hospital

Indianapolis, Indiana, 46202, United States

RECRUITING

MeSH Terms

Conditions

Eosinophilic EsophagitisGastroesophageal RefluxGastroparesisIrritable Bowel SyndromeConstipationFecal IncontinenceVomiting

Condition Hierarchy (Ancestors)

EsophagitisEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesGastroenteritisEosinophiliaLeukocyte DisordersHematologic DiseasesHemic and Lymphatic DiseasesHypersensitivity, ImmediateHypersensitivityImmune System DiseasesEsophageal Motility DisordersDeglutition DisordersStomach DiseasesParalysisNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsColonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesSigns and Symptoms, DigestiveRectal Diseases

Study Officials

  • John m Wo, MD

    Indiana University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lainna Cohen

CONTACT

Maureen Schilling

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Douglas Rex Professor of Gastroenterology and Hepatology; Director of GI Motility and Neurogastroenterology Unit

Study Record Dates

First Submitted

July 16, 2016

First Posted

August 10, 2020

Study Start

November 1, 2014

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

August 15, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

observational registry

Locations